|
J. Biol. Chem., Vol. 261, Issue 25, 11592-11599, 09, 1986
Immunoaffinity purification and characterization of thromboxane synthase from porcine lung
RF Shen and HH Tai
Thromboxane synthase has been purified 620-fold from porcine lung
microsomes by a three-step purification procedure including Lubrol-PX
solubilization, reactive blue-agarose chromatography, and immunoaffinity
chromatography. The purified enzyme exhibited a single protein band (53,000
daltons) on sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Rabbit antiserum raised against the purified enzyme immunoprecipitated
thromboxane synthase activity from crude enzyme preparations of porcine
lung, cow lung, and human platelets, indicating the existence of structural
homology of the enzyme in these species. Immunoblotting experiment
identified the same polypeptide (53,000 daltons) in porcine lung and a
polypeptide of 50,000 daltons in human platelets, confirming the identity
of the enzyme and the specificity of the antiserum. Purified thromboxane
synthase is a hemoprotein with a Soret-like absorption peak at 418 nm. The
enzyme reaction has a Km for 15-hydroxy-9 alpha, 11 alpha-peroxidoprosta-5,
13- dienoic acid of 12 microM, an optimal pH of 7.5, and an optimal
temperature of reaction at 30 degrees C. Purified thromboxane synthase
catalyzed the formation of both thromboxane B2 and 12-hydroxy-5,8,10-
heptadecatrienoic acid (HHT). The ratios of HHT to thromboxane B2 varied
from 1.6 to 2.1 dependent on the reaction conditions. Except that HHT was
formed at a greater rate, the formation of HHT and that of thromboxane
responded identically to pH, temperature, substrate concentration, kinetics
of formation, metal ions, and inhibitors suggesting that the two products
are probably formed at the same active site via a common intermediate.
Thromboxane synthase was irreversibly inactivated by 15-hydroxy-9 alpha, 11
alpha-peroxidoprosta-5,13-dienoic acid during catalysis and by treatment of
15- hydroperoxyeicosatetraenoic acid. The irreversible inactivation,
however, could be protected by reversible inhibitors such as sodium (E)-
3-[4-(1-imidazolylmethyl)phenyl]-2-propenoate and 15-hydroxy-11 alpha,9
alpha-(epoxymethano)-prosta-5,13-dienoic acid, suggesting that the
inactivation occurred at the active site of the enzyme. The catalytic
inactivation of thromboxane synthase and the greater rate of formation of
HHT in thromboxane-synthesizing system may probably play important
regulatory roles in the control of thromboxane synthesis.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. H. Wright, D. Abran, M. Bhattacharya, X. Hou, S. G. Bernier, A. Bouayad, J.-C. Fouron, A. Vazquez-Tello, M. H. Beauchamp, R. I. Clyman, et al.
Prostanoid receptors: ontogeny and implications in vascular physiology
Am J Physiol Regulatory Integrative Comp Physiol,
November 1, 2001;
281(5):
R1343 - R1360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhou, F. Yan, and H.-H. Tai
Phosphorylation and Desensitization of the Human Thromboxane Receptor-alpha by G Protein-Coupled Receptor Kinases
J. Pharmacol. Exp. Ther.,
September 1, 2001;
298(3):
1243 - 1251.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-Y. Hsu, A.-L. Tsai, R. J. Kulmacz, and L.-H. Wang
Expression, Purification, and Spectroscopic Characterization of Human Thromboxane Synthase
J. Biol. Chem.,
January 8, 1999;
274(2):
762 - 769.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1986 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|